|
1
|
Davis AS, Viera AJ and Mead MD: Leukemia:
An overview for primary care. Am Fam Physician. 89:731–738.
2014.PubMed/NCBI
|
|
2
|
Zhong S, Chen Z, Yu X, Chen W, Lv M, Ma T
and Zhao J: Tea consumption and leukemia risk: A meta-analysis.
Tumour Biol. 35:5205–5212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Greim H, Kaden DA, Larson RA, et al: The
bone marrow niche, stem cells, and leukemia: Impact of drugs,
chemicals, and the environment. Ann NY Acad Sci. 1310:7–31. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Laurier D, Grosche B, Auvinen A, et al:
Childhood leukaemia risks: From unexplained findings near nuclear
installations to recommendations for future research. J Radiol
Prot. 34:R53–R68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Malinge S, Chlon T, Doré LC, et al:
Development of acute megakaryoblastic leukemia in Down syndrome is
associated with sequential epigenetic changes. Blood. 122:e33–e43.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wakeford R: The risk of childhood
leukaemia following exposure to ionising radiation - a review. J
Radiol Prot. 33:1–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Woo JS, Alberti MO and Tirado CA:
Childhood B-acute lymphoblastic leukemia: A genetic update. Exp
Hematol Oncol. 3:162014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhatia S: Disparities in cancer outcomes:
Lessons learned from children with cancer. Pediatr Blood Cancer.
56:994–1002. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carranza C, Granados L, Morales O, et al:
Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1
fusion genes in Guatemalan pediatric acute lymphoblastic leukemia
patients and their ethnic associations. Cancer Genet. 206:227–232.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goggins WB and Lo FF: Racial and ethnic
disparities in survival of US children with acute lymphoblastic
leukemia: Evidence from the SEER database 1988–2008. Cancer Causes
Control. 23:737–743. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kennedy AE, Kamdar KY, Lupo PJ, et al:
Genetic markers in a multi ethnic sample for childhood acute
lymphoblastic leukemia risk. Leuk Lymphoma. 56:169–174. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Savage SA: Genomic clues to ethnic
differences in ALL. Blood. 123:2440–2442. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lim JY, Bhatia S, Robison LL and Yang JJ:
Genomics of racial and ethnic disparities in childhood acute
lymphoblastic leukemia. Cancer. 120:955–962. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Adkins RM, Krushkal J, Tylavsky FA and
Thomas F: Racial differences in gene-specific DNA methylation
levels are present at birth. Birth Defects Res A Clin Mol Teratol.
91:728–736. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xia YY, Ding YB, Liu XQ, et al:
Racial/ethnic disparities in human DNA methylation. Biochim Biophys
Acta. 1846:258–262. 2014.PubMed/NCBI
|
|
16
|
Baylin SB and Jones PA: A decade of
exploring the cancer epigenome - biological and translational
implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Plass C, Pfister SM, Lindroth AM, et al:
Mutations in regulators of the epigenome and their connections to
global chromatin patterns in cancer. Nat Rev Genet. 14:765–780.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang D, Hong Q, Shen Y, et al: The
diagnostic value of DNA methylation in leukemia: A systematic
review and meta-analysis. PLoS One. 9:e968222014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H
and Moons KG: More than numbers: The power of graphs in
meta-analysis. Am J Epidemiol. 169:249–255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pluta A, Nyman U, Joseph B, Robak T,
Zhivotovsky B and Smolewski P: The role of p73 in hematological
malignancies. Leukemia. 20:757–766. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cahill N and Rosenquist R: Uncovering the
DNA methylome in chronic lymphocytic leukemia. Epigenetics.
8:138–148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Esteller M: CpG island hypermethylation
and tumor suppressor genes: A booming present, a brighter future.
Oncogene. 21:5427–5440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao Y, Guo J, Zhang X, et al:
Downregulation of p21 in myelodysplastic syndrome is associated
with p73 promoter hypermethylation and indicates poor prognosis. Am
J Clin Pathol. 140:819–827. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Volodko N, Gordon M, Salla M, Ghazaleh HA
and Baksh S: RASSF tumor suppressor gene family: Biological
functions and regulation. FEBS Lett. 588:2671–2684. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Benezra R, Davis RL, Lockshon D, Turner DL
and Weintraub H: The protein Id: A negative regulator of
helix-loop-helix DNA binding proteins. Cell. 61:49–59. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bodoor K, Haddad Y, Alkhateeb A, et al:
DNA hypermethylation of cell cycle (p15 and p16) and apoptotic
(p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia
patients. Asian Pac J Cancer Prev. 15:75–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chmelařová M, Křepinská E, Spaček J, Laco
J, Nekvindová J and Palička V: Methylation analysis of tumour
suppressor genes in ovarian cancer using MS-MLPA. Folia Biol
(Praha). 58:246–250. 2012.PubMed/NCBI
|
|
29
|
Cechova H, Lassuthova P, Novakova L, et
al: Monitoring of methylation changes in 9p21 region in patients
with myelodysplastic syndromes and acute myeloid leukemia.
Neoplasma. 59:168–174. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deligezer U, Erten N, Akisik EE and Dalay
N: Methylation of the INK4A/ARF locus in blood mononuclear cells.
Ann Hematol. 85:102–107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsiao PC, Liu MC, Chen LM, et al: Promoter
methylation of p16 and EDNRB gene in leukemia patients in Taiwan.
Chin J Physiol. 51:27–31. 2008.PubMed/NCBI
|
|
32
|
Zheng R, Shen S, Shen J and Ma X: Studies
on p16, p15, p18 and p19 methylation of INK4 series cancer
inhibitive gene in leukemia. J Fujian Med Univ. 38:257–260.
2004.
|
|
33
|
Xiao Y, Liu Y, Jiang L and Ran L: Study on
the deletion point mutation and promoter methylation analysis of
p16 in leukemia. Guizhou Med J. 34:784–787. 2010.
|
|
34
|
Yang J, Li X, Sun L, Song G, Chen H and
Liu Y: Expression of p16 gene in adult acute leukemia. J Zhengzhou
Univ (Med Sci Ed.). 38:33–36. 2003.
|
|
35
|
Song G, Yang J, Sun H, Liu C, Chen H and
Li X: Deletion and methylation of p16 gene in an adult acute
leukemia. Henan J Oncol. 17:229–231. 2004.
|
|
36
|
Tan G and Guo X: Methods of CpG islands
methylation detection. J Jinan Univ. 22:24–26. 2001.
|
|
37
|
Zhu C, Xu W, Liu D, Wang Y and Bi K: Study
of the methylation of p15 and p16 gene in acute leukemia. Shandong
Med J. 45:4–5. 2005.
|
|
38
|
Zhang J, Wu J and Tan Y: The relationship
between P16 gene inactivation and expression of mRNA in ALL. J
Wenzhou Med Coll. 30:5–7. 2000.
|
|
39
|
Fan L, Shen J, Ye B, et al: Detection of
p16 gene methylation status in adult patients with acute leukemia
by using n-MSP. J Exp Hematol. 15:258–261. 2007.
|
|
40
|
Jiang J, Shen J, Yan J, et al: The value
of p15 gene methylation in minimal residual disease of childhood
acute leukemia by MSP. China Child Blood. 7:1–3. 2002.
|
|
41
|
Meng Y, Yu H, Guo C, et al: Quantitative
analysis of p15 and p16 gene methylation and mRNA expression levels
in acute leukemia patients. Chin J Hematol. 26:434–435. 2005.
|
|
42
|
Wang B: The clinical significance of p16
gene methylation in leukemia and other hematologic malignancies.
Master's degree dissertation, China Medical University. 2002.
|
|
43
|
Yin Y: The clinical significance of p15
gene methylation in leukemia and other hematologic malignancies.
Master's degree dissertation, China Medical University. 2002.
|
|
44
|
Chen H, Sun H, Liu C, Liu Y, Song G and Li
X: Methylation of p16/p15 exon 2 in adult acute myeloid leukemia. J
Zhengzhou Univ (Med Sci Ed.). 38:722–724. 2003.
|
|
45
|
Lin F, Ye B, Shen J, et al: Detection of
p15 methylation and deletion status in acute lymphoblastic leukemia
using hn-MSP. J Leuk Lymphoma. 21:208–212. 2012.
|
|
46
|
Zhu C, Bi K and Liu X: Homozygous deletion
and methylation of P15 gene in acute laukemia. Shandong Med J
Shandong Yiyao. 41:10–11. 2001.
|
|
47
|
Shen Z, Zhang J, Yu K and Jiang S:
Evaluation of methylation-specific polymerase chain reaction and
its potential clinical value in detecting minimal residual disease
of adult acute leukemia with P15. J Wenzhou Med Coll. 32:230–232.
2002.
|
|
48
|
Fan H, Guo X, Tan G, Wu Q, Zhou T and Guo
Q: Study on methylation of p15 INK4B in myelodysplastic syndrome.
Chin J Pathophysiol. 17:349–352. 2001.
|
|
49
|
Tong H and Lin M: Methylation of p15INK4B
gene and its mechanism in patients with myelodysplastic syndrome
and leukemia. Chin J Pathophysiol. 20:2257–2260. 2004.
|
|
50
|
Guo X, Fan H, Wu Q, et al: Study on
methylation of p15INK4B gene in acute myeloid leukemia and chronic
myeloid leukemia. J Exp Hematol. 8:257–260. 2000.
|
|
51
|
Qiao S, Xu S, Guo X and Wang Y: Clinical
significance of the expression of DNA methyltransferase genes
(DNMT) in acute leukemia patients. J Exp Hematol. 13:260–265.
2005.
|
|
52
|
Chen F and Zeng X: Detection of p15 gene
hypermethylation in acute leukemia by MSP. Chin J Hematol.
21:2502000.
|
|
53
|
Yin Y, Li Y and Liu D: The clinical
significance of p15 gene methylation in leukemia and other
hematologic malignancies. Chin J Hematol. 24:383–384. 2003.
|
|
54
|
Wu D: p15INK4b gene DNA methylation and
histone modification mechanism of leukemia cell mediated by
p15-piRNAs. PhD dissertation, Fujian Medical University. 2013.
|
|
55
|
Wang H: The study of p15 gene methylation
in malignancies. Master's degree dissertation, Qingdao University.
2002.
|
|
56
|
Zhao Y, Wang QS, Li HH, et al:
[Significance of id4 promoter methylation in monitoring AML
patients with completely remission]. J Exp Hematol. 16:476–478.
2008.
|
|
57
|
Wang X, Kang H, Cen J, Li Y, Wang L and Yu
L: Methylation Status of id4 gene promoter in patients with chronic
myeloid leukemia. J Exp Hematol. 18:1402–1404. 2010.
|
|
58
|
Liu F, Xu R, Cui X, Zhang X and Wang Y:
ID4 promoter methylation in acute myeloid leukemia. J Exp Hematol.
19:582–584. 2011.
|
|
59
|
Jie X: WT1, ID4, GLIPR1 aberrant gene
promoter methylation and mRNA expression in leukemia patients.
Master's degree dissertation, Guangdong Medical College. 2012.
|
|
60
|
Zhao Y: The significance of Id4 gene
methylation in hematological malignancies. PhD dissertation, PLA
Postgraduate Medical School. 2005.
|
|
61
|
Xiao YH, Li XH, Tan T, et al:
Identification of GLIPR1 tumor suppressor as methylation-silenced
gene in acute myeloid leukemia by microarray analysis. J Cancer Res
Clin Oncol. 137:1831–1840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Liang T, Tan T, Xiao Y, et al: Methylation
and expression of glioma pathogenesis-related protein 1 gene in
acute myeloid leukemia. J Cent South Univ (Med Sci Ed.).
34:388–394. 2009.
|
|
63
|
Zhang Y, Gao Y, Wang X, et al: The
relationship between p73 gene methylation and childhood acute
leukemia. Proceedings of the Ninth National Conference on
Environmental and Occupational Medicine Graduate (Shanghai, China).
254–256. 2010.
|
|
64
|
Zhang H, Mo W and Yang Z: The expression
of WWOX and p73 in acute myeloid leukemia. Guangdong Med J.
33:1567–1570. 2012.
|
|
65
|
Wu C, Jin J, Ji Y, et al: Abnormal
expression and significance of p73 gene in adult acute
lymphoblastic leukemia. Jiangsu Med J. 34:339–341. 2008.
|
|
66
|
Liu J, Jiang Y, Xu W and Liang X:
Alterations of p53 and p73 genes in lympho-plasmacytic diseases.
Pract Clin Med. 6:9–13. 2005.
|
|
67
|
Xu W: Study on methylation of the p73 gene
in acute lymphoblastic leukemia and its clinical significances.
Chin J Pract Int Med. 25:905–906. 2005.
|
|
68
|
Yu G: Abnormal expression of p73 gene in
adult acute lymphoblastic leukemia. Med Innov Chin. 2:121–122.
2014.
|
|
69
|
Xie X, Chen Z, Zhang X and Huang M:
Detecting methylation of the calcitonin gene in monitoring
treatment and disease evolution for myelogenous leukemia. Chin J
Cancer. 22:616–619. 2003.
|
|
70
|
Tang Y, Deng C, Du Q and Li G: Study on
hypermethylation of the calcitonin gene in malignant hematological
disorders. J West Chin Univ Med Sci. 32:86–88. 2001.
|
|
71
|
Wang S, Hong W and Peng A: The study of CT
gene methylation in chronic myeloid leukemia. Chin J Hematol.
19:321998.
|
|
72
|
Qian J, Yao D, Lin J, et al: Alteration of
methylation status of death-associated protein kinase (dapk) gene
promoter in patients with acute myeloid leukemia. J Exp Hematol.
18:1390–1394. 2010.
|
|
73
|
Niu Y, Wang P, Wang Y, Wang Y, Cai D and
Li Y: Expression of death-associated protein kinase gene and
methylation status of promoter region in acute leukimia. J Exp
Hematol. 22:30–34. 2014.
|
|
74
|
Zhao W: DAPK gene promoter methylation,
expression and biological function in acute leukemia. PhD
dissertation, Southern Medical University. 2009.
|
|
75
|
Qian J, Wang YL, Lin J, Yao DM, Xu WR and
Wu CY: Aberrant methylation of the death-associated protein kinase
1 (DAPK1) CpG island in chronic myeloid leukemia. Eur J Haematol.
82:119–123. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Lin W, Ye Z and Tan J: Gene methylation
abnormalities in chronic lymphocytic leukemia patients by PCR. J
Qiqihar Med Coll. 31:2376–2377. 2010.
|
|
77
|
Wu B, Chen E and Zhu B: Detecting the
aberrant methylation of progesterone receptor B gene in human
chronic lymphocytic leukemia by MSP. Chin J Hemorheol. 18:140–141.
2008.
|
|
78
|
Zhang X: The experimental study of PR
promoter CpG island methylation in leukemia. Master's degree
dissertation, Third Military Medical University. 2003.
|
|
79
|
Shi X, Chang N, Fan Y, et al: Detection
and clinical significance of SFRP2 promoter methylation status in
patients with acute myeloid leukemia. Chin J Clin, Electron Ed.
5:1962–1966. 2011.
|
|
80
|
Wang H, Zhang G, Yao K, et al: The gene
methylation and protein expression of SFRP5 in leukemic cells. J
China Med Univ. 41:2012.
|
|
81
|
Xu C, Shen J, Shen S, Fu H, Zhu Y and Chen
L: The significance of methylation status of secreted
frizzled-related protein gene promoter in acute leukemia. Chin J
Intern Med. 49:769–771. 2010.
|
|
82
|
Li M: A preliminary study of inactivation
of IGSF4 gene methylation in leukemia cell. PhD dissertation, PLA
Postgraduate Medical School. 2004.
|
|
83
|
Chen W, Huang C, Zhan X, et al: RASSF1A
gene methylation and its clinical significance in leukemia
patients. Lab Med. 27:554–556. 2012.
|
|
84
|
Song J, Li Y, Yang Z, Yang L and Chen J:
Hypermethylation in SFRP2 promoter in human leukemia K562 cells and
bone marrow specimen with chronic myeloid leukemia. Acad J Third
Med Coll PLA. 33:2583–2586. 2011.
|
|
85
|
Dou L: The study of LRP15 gene methylation
in blood diseases. Master's degree dissertation, PLA Postgraduate
Medical School. 2004.
|
|
86
|
Yao C, Fang J, Gao L, Ding J, Shu G and Yu
W: Study on the relationship between the RIZ1 gene expression and
methylation status of the gene promoter in acute myeloid leukemia.
J Southeast Univ (Med Sci Ed.). 29:119–122. 2010.
|
|
87
|
Cai F: RIZ1 gene expression and promoter
methylation status in acute childhood leukemia. PhD dissertation,
Huazhong University Science and Technology. 2012.
|
|
88
|
Shi X, Fan Y, Zhou C, et al: Study of
abnormal methylation in the promoter region of SFRP4 gene in acute
myeloid leukemia. Chin J Clin, Electron Ed. 5:990–995. 2011.
|
|
89
|
Dou LP, Liu JH, Wang C, et al: [Study on
the involvement of ZO-1 gene in leukemogenesis]. Chin J Hematol.
30:473–476. 2009.
|
|
90
|
Wang C, Wang G, Tan Y, Li W, Liu C and Yu
L: The methylation pattern and clinical significance of Zonula
occludens-1 gene promoter in acute leukemia. Chin J Intern Med.
47:111–113. 2008.
|
|
91
|
Chim CS, Wong SY, Pang A, et al: Aberrant
promoter methylation of the retinoic acid receptor alpha gene in
acute promyelocytic leukemia. Leukemia. 19:2241–2246. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Wang G, Liu L, Chen J, et al: Promoter
methylation profile of androgen receptor gene in leukemic cells. J
Third Mil Med Univ. 29:932–934. 2007.
|
|
93
|
Wang X, Li J, Fu B, Guo L, Zhang J and
Huang S: Methylation Status of JunB and CDH13 gene promoter in CD34
CD38−chronic myelogenous leukemia cells. J Exp Hematol.
17:1405–1408. 2009.
|
|
94
|
Liu J: CDH13 gene promoter methylation and
expression in acute myeloid leukemia. Master's degree dissertation,
Guangzhou Medical University. 2013.
|
|
95
|
Wang Y: The study of DDIT3 gene promoter
methylation in hematological tumors. Master's degree dissertation,
Jiangsu University. 2009.
|
|
96
|
Zhu X, Zhu C, Wan Y, et al: Analysis of
methylation of the Dickkopf1 (DKK-1) gene in acute leukemia. J
Shandong Univ (Health Sci). 50:84–87. 2012.
|
|
97
|
Yuan X: The study of EDNRB gene promoter
methylation in acute leukemia. Master's degree dissertation,
Zhengzhou University. 2010.
|
|
98
|
Yu Y: The study of FANCF methylation in
patients with acute myeloid leukemia and myelodysplastic syndrome.
Master's degree dissertation, China Medical University. 2008.
|
|
99
|
Deng N: The study of FANCF/FANCD2
expression in patients with acute myeloid leukemia and
myelodysplastic syndrome. Master's degree dissertation, China
Medical University. 2009.
|
|
100
|
Qian Z: The significance of GRAF gene
promoter methylation in hematopoietic tumors. Master's degree
dissertation, Jiangsu University. 2010.
|
|
101
|
Chen Q: HAGE gene promoter hypomethylation
in myeloid tumors. Master's degree dissertation, Jiangsu
University. 2012.
|
|
102
|
Li Y, Wang Y, Zhou J, Zhou S, Fang G and
Liu X: Analysis and clinical significance of hPer3 promoter
methylation status for CML monitoring. Chin J Pathophysiol.
27:2111–2115. 2011.
|
|
103
|
Wang Y, Zhou J, Zhou S, et al: Promoter
methylation status of hPer3 gene in AML patients and the in
vitro effect of decitabine on the status. Chin J Hematol.
32:317–321. 2011.
|
|
104
|
Wang N: MiR-34b expression, methylation
regulation and clinical significance in acute childhood leukemia.
Master's degree dissertation, Suzhou University. 2013.
|
|
105
|
Chai H: RAGE-1 gene promoter
hypomethylation in myeloid tumors. Master's degree dissertation,
Shanxi Medical University. 2013.
|
|
106
|
Lin D, Fan R and Liu X: Significance of
DNA methylation status of runx3 gene promoter region in acute
leukemia. J Exp Hematol. 16:263–266. 2008.
|
|
107
|
Chim CS, Wong AS and Kwong YL: Epigenetic
dysregulation of the Jak/STAT pathway by frequent aberrant
methylation of SHP1 but not SOCS1 in acute leukaemias. Ann Hematol.
83:527–532. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Wang Y, Zhu CS, Bi KH, Xu WW, Dong L and
Hou M: [Study of WIF-1 promoter methylation with expressions of
β-catenin in acute leukemia]. Chin Med J. 91:2858–2860. 2011.
|
|
109
|
Liu W, Xu C, Guan M and Zhang Y: Aberrant
promoter hypermethylation of AKAP12 gene in acute lymphoblastic
leukemia in children. Lab Med. 23:344–348. 2008.
|
|
110
|
Gao F, Li Y, Liu W, et al: Studies on gene
expression and the 5′ CpG islands methylation status of E-cadherin
in acute myeloid leukemia. Chin J Hematol. 27:25–27. 2006.
|
|
111
|
Yao DM, Qian J, Lin J, et al: Aberrant
methylation of CCAAT/enhancer binding protein zeta promoter in
acute myeloid leukemia. Leuk Res. 35:957–960. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Guan M, Xu C, Liu W and Chen B:
Identification of aberrant methylation of DLC-1 by pyrosequencing
in acute lymphoblastic leukemia in children. Chin J Lab Med.
31:389–393. 2008.
|
|
113
|
Yu L, Wang Q, Gu Q, Shi Z and Jin H: Study
on aberrant DNA methylation of dopamine D4 receptor gene in acute
myeloid leukemia. Acad J Chin PLA Postgrad Med Sch. 21:62–64.
2000.
|
|
114
|
Tao YF, Xu LX, Lu J, et al:
Metallothionein III (MT3) is a putative tumor suppressor gene that
is frequently inactivated in pediatric acute myeloid leukemia by
promoter hypermethylation. J Transl Med. 12:1822014. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Zheng Y: Abnormal methylation of the
promoter region of the p53 gene in acute leukemia. Master's degree
dissertation, Sun Yat-sen University. 2007.
|
|
116
|
Li Y, Qian J, Chen Q, et al: Expression
pattern and promoter hypermethylation of PDLIM4 gene in patients
with chronic myeloid leukemia. J Jiangsu Univ (Med Ed.). 23:17–21.
2013.
|
|
117
|
Song JJ, Liu Q, Li Y, et al: Epigenetic
inactivation of PLCD1 in chronic myeloid leukemia. Int J Mol Med.
30:179–184. 2012.PubMed/NCBI
|
|
118
|
Yao D, Qian J, Lin J, Li Y, Chen Q and
Chen X: Alteration of methylation status of PRAME gene promoter in
patients with chronic myeloid leukemia. J Pract Med. 29:3495–3498.
2013.
|
|
119
|
Yan W, Hu W and Yang W: Expression and
methylation study of PRDX2 gene in acute myeloid leukemia. J China
Med Univ. 41:1047–1049. 2012.
|
|
120
|
Yang J, Du W, He Y, Liu J, Zheng J and
Huang S: Research on PTEN expression and its promoter methylation
in B-ALL patients. J Intern Intens Med. 13:141–143. 2007.
|
|
121
|
Du C, Mao P and Wang Y: The clinical
significance of the RIL gene methylation levels in acute myeloid
leukemia. China J Mod Med. 23:46–51. 2013.
|
|
122
|
Jiao X, Chen Q, Lin J, et al: SALL4 genes
methylation changes and clinical significance in acute myeloid
leukemia patients. J Jiangsu Univ (Med Ed.). 23:532–535. 2013.
|
|
123
|
Zhuang Y, Cheng Y, Wang L, Dou H, Zhu Q
and Hu J: The methylation of SOCS-1 gene in adult acute myeloid
leukemia. Prog Mod Biomed. 18:3417–3420. 2011.
|
|
124
|
Deng G, Li ZQ, Zhao C, et al: WNT5A
expression is regulated by the status of its promoter methylation
in leukaemia and can inhibit leukemic cell malignant proliferation.
Oncol Rep. 25:367–376. 2011.PubMed/NCBI
|
|
125
|
Iacobucci I, Ferrari A, Lonetti A, et al:
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive
acute lymphoblastic leukemia patients. Clin Cancer Res.
17:7413–7423. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Hu HB and Hu Q: ID4 methylation patterns
in childhood T line and B line lymphocytic leukemia. Chin J Contemp
Pediatr. 12:940–942. 2010.(In Chinese).
|
|
127
|
Chen SS, Claus R, Lucas DM, et al:
Silencing of the inhibitor of DNA binding protein 4 (ID4)
contributes to the pathogenesis of mouse and human CLL. Blood.
117:862–871. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Liu Y, Kang HY, Wang LL, Lu XC, Zhu HL and
Yu L: Establishment of methylation-specific quantitative PCR system
for ID4 gene in acute leukemia cells and its specificity and
sensitivity. J Exp Hematol. 22:269–274. 2014.(In Chinese).
|
|
129
|
Liu F and Xu RR: Study on the correlation
between Chinese medical syndrome types and ID4 gene promoter
methylation in human acute myeloid leukemia. Chin J Integr Tradit
West Med. 32:471–473. 2012.(In Chinese).
|
|
130
|
Awasthi A, Woolley AG, Lecomte FJ, et al:
Variable expression of GLIPR1 correlates with invasive potential in
melanoma cells. Front Oncol. 3:2252013. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Capalbo G, Mueller-Kuller T, Koschmieder
S, et al: Endoplasmic reticulum protein GliPR1 regulates G protein
signaling and the cell cycle and is overexpressed in AML. Oncol
Rep. 30:2254–2262. 2013.PubMed/NCBI
|
|
132
|
He Z, Liu H, Agostini M, et al: p73
regulates autophagy and hepatocellular lipid metabolism through a
transcriptional activation of the ATG5 gene. Cell Death Differ.
20:1415–1424. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Toska E and Roberts SG: Mechanisms of
transcriptional regulation by WT1 (Wilms tumour 1). Biochem J.
461:15–32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Dores GM, Devesa SS, Curtis RE, Linet MS
and Morton LM: Acute leukemia incidence and patient survival among
children and adults in the United States, 2001–2007. Blood.
119:34–43. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Shirley MH, Sayeed S, Barnes I, Finlayson
A and Ali R: Incidence of haematological malignancies by ethnic
group in England, 2001-7. Br J Haematol. 163:465–477. 2013.
View Article : Google Scholar : PubMed/NCBI
|
